Recombinant tissue Plasminogen activator for the treatment of acute ischemic stroke at Thainguyen Central Hospital

To evaluate the results and factors affecting intravenous thrombolysis in the treatment of acute ischemic stroke in Thainguyen Central Hospital. Subjects and methods: 50 patients with acute ischemic stroke were done intravenous thrombolysis at Thainguyen Central Hospital from December 2016 to June 2018, meeting inclusive and exclusive criteria as directed by American Stroke Association (AHA/ASA), according to cross-sectional descriptive study. Treatment outcomes were assessed at hospital discharge and 1 month by NIHSS and modified Rankin Scale (mRS).
Nội dung trích xuất từ tài liệu:
Recombinant tissue Plasminogen activator for the treatment of acute ischemic stroke at Thainguyen Central Hospital